Mobius Care, a Cleveland Clinic-founded company that is pioneering a new approach to precision medicine for patients with Inflammatory Bowel Disease (IBD), today announced it has received funding from the Crohn’s & Colitis Foundation. The Foundation is a non-profit organization committed to finding cures for Crohn’s disease and ulcerative colitis.

Dr. Thaddeus Stappenbeck, the company's founder, shared insights on Mobius Care's innovative precision medicine approach for IBD treatment. The summit provided valuable opportunities for collaboration with industry leaders and reinforced our commitment to transforming IBD treatment through precision medicine.